Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Veracyte Inc

12V
Current price
34.8 EUR 0 EUR (0.00%)
Last closed 37.04 USD
ISIN US92337F1075
Sector Healthcare
Industry Diagnostics & Research
Exchange Frankfurt Exchange
Capitalization 3 013 959 424 USD
Yield for 12 month +42.34 %
1Y
3Y
5Y
10Y
15Y
12V
21.11.2021 - 28.11.2021

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

42 USD

P/E ratio

Dividend Yield

Current Year

+361 051 000 USD

Last Year

+296 536 000 USD

Current Quarter

+115 860 000 USD

Last Quarter

+114 428 000 USD

Current Year

+223 152 000 USD

Last Year

+194 954 000 USD

Current Quarter

+79 010 000 USD

Last Quarter

+75 785 000 USD

Key Figures 12V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 44 014 000 USD
Operating Margin TTM 10.53 %
PE Ratio
Return On Assets TTM 1.07 %
PEG Ratio
Return On Equity TTM -0.83 %
Wall Street Target Price 42 USD
Revenue TTM 425 331 008 USD
Book Value 15.18 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 28.6 %
Dividend Yield
Gross Profit TTM 194 954 000 USD
Earnings per share -0.13 USD
Diluted Eps TTM -0.13 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -2.18 %

Dividend Analytics 12V

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 12V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 12V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 38.61
Enterprise Value Revenue 6.0489
Price Sales TTM 7.0862
Enterprise Value EBITDA 149.2344
Price Book MRQ 2.404

Financials 12V

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 12V

For 52 weeks

18.61 USD 41.43 USD
50 Day MA 33.27 USD
Shares Short Prior Month 3 263 081
200 Day MA 25.74 USD
Short Ratio 3.8
Shares Short 3 099 723
Short Percent 4.5 %